SkylineDx
PrivateLast Round
Grant
Dec 11, 2023
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SkylineDx operates in Healthcare & Life Sciences and is based in Rotterdam. Its latest recorded funding round was a VC Round in December 2021.
SkylineDx is a biotechnology company that develops and commercializes gene signature-based diagnostic tests to assist healthcare professionals in personalized treatment decision-making.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SkylineDx Comparables
Compare SkylineDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AMLo Biosciences | 84% | |
| NeraCare | 80% | |
| Castle Biosciences, Inc. | 79% |
For institutional investors. Book with your work email.
SkylineDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2023 | ||||
| VC Round | Dec 21, 2021 | ||||
| VC Round | Sep 2, 2019 | ||||
| Grant | Oct 4, 2016 |
For institutional investors. Book with your work email.
SkylineDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Novalis LifeSciences | VC Round |
| VIB | Grant |
| Stichting Van Herk Investments | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 5, 2026
Named Diagnostics Company of the Year for the second consecutive year.
- Aug 21, 2026
Monthly visitors grew 64% MoM, reaching 5.7K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardNov 5, 2026
On Nov 5th '26 in Netherlands, SkylineDx BV receives the 2026 BioTech Breakthrough award for "Diagnostics Company of the Year" from the BioTech Breakthrough Awards program for the second consecutive year, recognizing its dedication to advancing precision molecular diagnostics.
- attends_eventNov 5, 2026
SkylineDx BV is named Diagnostics Company of the Year for the second consecutive year at the sixth annual BioTech Breakthrough Awards on Nov 5th '26 for its portfolio of molecular tests addressing unmet needs in specialty oncology.
- recognized_asNov 5, 2026
On Nov 5th '26, SkylineDx BV is named Diagnostics Company of the Year for the second consecutive year in the sixth annual BioTech Breakthrough Awards program in Netherlands and California.
- expands_offices_inSep 9, 2026
SkylineDx BV expands its direct U.S. commercial and clinical presence with a fully integrated organization of more than 25 professionals on Sep 9th '26.
For institutional investors. Book with your work email.
SkylineDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SkylineDx's valuation, stock price, and market status.
Is SkylineDx a public or private company?
SkylineDx is a private company.
What is the current stock price of SkylineDx?
SkylineDx is a private company, so its shares have no public market price. Caplight tracks SkylineDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SkylineDx worth (valuation)?
Valuation information for SkylineDx is not publicly available.
Can I buy SkylineDx stock?
SkylineDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SkylineDx's last funding round?
SkylineDx's most recent funding round was Grant on December 11, 2023.
Who are the main investors in SkylineDx?
Key investors in SkylineDx include Novalis LifeSciences, Stichting Van Herk Investments.
Will SkylineDx IPO soon?
No public IPO plans have been announced for SkylineDx.
How can I track SkylineDx secondary market activity?
Caplight tracks bids, offers, and trades in SkylineDx's shares on secondary markets.